Castle Biosciences, Inc. (CSTL)
39.05
-0.84
(-2.11%)
USD |
NASDAQ |
Jan 09, 13:32
Castle Biosciences Research and Development Expense (Annual): 51.69M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 44.58M |
| Delcath Systems, Inc. | 13.87M |
| Star Operating Cos., Inc. | -- |
| CorMedix, Inc. | 3.942M |
| CytoSorbents Corp. | 6.916M |